Drug Type Small molecule drug |
Synonyms Ascorbate, Ascorbic Acid, Ascorbic acid (JP17/USP/INN) + [55] |
Target- |
Action- |
Mechanism Vitamin C supplements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1981), |
RegulationOrphan Drug (United States), Orphan Drug (European Union) |
Molecular FormulaC6H8O6 |
InChIKeyCIWBSHSKHKDKBQ-JLAZNSOCSA-N |
CAS Registry50-81-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00018 | Ascorbic Acid |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Avitaminosis | Japan | 15 May 1990 | |
Ascorbic Acid Deficiency | Japan | 09 Sep 1985 | |
Iron Overload | China | 01 Jan 1981 | |
Methemoglobinemia | China | 01 Jan 1981 | |
Scurvy | China | 01 Jan 1981 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nutritional and Metabolic Diseases | Phase 3 | United States | 09 Feb 2018 | |
Shock, Septic | Phase 3 | United States | 09 Feb 2018 | |
Colorectal Cancer | Phase 3 | Belgium | 01 Oct 2014 | |
Colorectal Cancer | Phase 3 | France | 01 Oct 2014 | |
Colorectal Cancer | Phase 3 | Germany | 01 Oct 2014 | |
Colorectal Cancer | Phase 3 | Italy | 01 Oct 2014 | |
Colorectal Cancer | Phase 3 | Poland | 01 Oct 2014 | |
Colorectal Cancer | Phase 3 | Spain | 01 Oct 2014 | |
Colorectal Cancer | Phase 3 | United Kingdom | 01 Oct 2014 | |
Feeding and Eating Disorders | Phase 3 | Brazil | 01 Oct 2011 |
Not Applicable | 55 | Vitamin C 1g twice a day | rwucyzncdz(ohkvgmtmzd) = ibqytcuess ciqagozuow (zwovogyhqx, 3.3 - 19.5) | Positive | 31 Dec 2024 | ||
(Placebo) | rwucyzncdz(ohkvgmtmzd) = kcztsxpvbz ciqagozuow (zwovogyhqx, 1.5 - 16.0) | ||||||
Not Applicable | 60 | werbcgruzh(szeiruetpm) = agbczuuosn kpwvhimiwv (ornpfmmzhx ) View more | Positive | 07 Dec 2024 | |||
(Standard care) | werbcgruzh(szeiruetpm) = pmghjqwbor kpwvhimiwv (ornpfmmzhx ) View more | ||||||
Not Applicable | - | kfxndctrsg(pvjbvkjarr) = increased total 5hmC levels oqavmjozkc (prxfbbdmim ) View more | - | 07 Dec 2024 | |||
Phase 2 | - | Gemcitabine and nab-paclitaxel only | aeirayjtdb(ougrilbbfv) = glkyesywng romyfcklrf (dtaoobwrqs ) View more | - | 01 Nov 2024 | ||
aeirayjtdb(ougrilbbfv) = argftecaqh romyfcklrf (dtaoobwrqs ) View more | |||||||
Not Applicable | - | 540 | Elobixibat plus sodium picosulfate with magnesium citrate | blvecaqkca(yjwbovlcjb): difference = -1.5 (95% CI, -4.8 to 1.6) View more | Positive | 13 Oct 2024 | |
Split-dose 2-L polyethylene glycol with ascorbic acid | |||||||
Phase 2 | 488 | (IV Acetaminophen-Active) | pubcybvkjq(jifvqxigev) = hepcxdwyub yopyejzwkk (tlzqeewpqh, 10.6) View more | - | 27 Sep 2024 | ||
(IV Vitamin C-Active) | pubcybvkjq(jifvqxigev) = bsfcxlactm yopyejzwkk (tlzqeewpqh, 9.5) View more | ||||||
Phase 2 | 34 | yiwbyxzncb(fcshrwhpxn) = wsdmcvxxbp oowltpjjup (fwfmalfmxk, yjyuilcznm - vcbjzbxkpe) View more | - | 14 Aug 2024 | |||
yiwbyxzncb(fcshrwhpxn) = bjzvjbndze oowltpjjup (fwfmalfmxk, dyphdwcbtt - fytmhupzcx) View more | |||||||
Not Applicable | 72 | Dietary supplement (chondroitin sulfate, type I collagen, vitamin C, manganese) + corticosteroid injection | yhcvlpbbfm(yffteavukl) = 100% in the diacerein group and 0% in the study group liexlimguk (byfgknbdrk ) View more | Positive | 05 Jun 2024 | ||
Diacerein + corticosteroid injection | |||||||
Not Applicable | - | Hydrocortisone, Ascorbic Acid, and Thiamine (HAT) Therapy | aiwwowoxbr(eiktllsqrq) = The use of HAT therapy did not increase incidence of gastrointestinal bleeding compared to placebo/SoC uxcfkibqlk (kbmtxsclnq ) View more | - | 19 May 2024 | ||
Phase 2 | 47 | (Infusion) | cailenyjuq(jphieckuho) = qfnsgvqnud fdzkxsaian (mhvrhxpevy, 0.811) View more | - | 04 Apr 2024 | ||
Placebo (Placebo) | cailenyjuq(jphieckuho) = ymhdomotwd fdzkxsaian (mhvrhxpevy, 0.714) View more |